Amifostine
-
Subject Areas on Research
- A Phase II trial of subcutaneous amifostine and radiation therapy in patients with head-and-neck cancer.
- Amifostine protects against cisplatin-induced ototoxicity in children with average-risk medulloblastoma.
- Assessment and management of cutaneous reactions with amifostine administration: findings of the ethyol (amifostine) cutaneous treatment advisory panel (ECTAP).
- Assessment of the protective effect of amifostine on radiation-induced pulmonary toxicity.
- Cytoprotection for radiation-associated normal tissue injury.
- Does amifostine have a role in chemoradiation treatment?
- Effect of amifostine on patient assessed clinical benefit in irradiated head and neck cancer.
- Effect of amifostine on survival among patients treated with radiotherapy: a meta-analysis of individual patient data.
- Has the outlook improved for amifostine as a clinical radioprotector.
- Hematopoietic growth factors in cancer chemotherapy.
- Influence of WR 2721 on radiation response of canine soft tissue sarcomas.
- Influence of intravenous amifostine on xerostomia, tumor control, and survival after radiotherapy for head-and- neck cancer: 2-year follow-up of a prospective, randomized, phase III trial.
- Oxidative stress and inflammation contribute to lung toxicity after a common breast cancer chemotherapy regimen.
- Phase III randomized trial of amifostine as a radioprotector in head and neck cancer.
- Phase III randomized trial of amifostine as a radioprotector in head and neck cancer.
- Radiation effects and radioprotection in MC3T3-E1 mouse calvarial osteoblastic cells.
- Radioprotection of lungs by amifostine is associated with reduction in profibrogenic cytokine activity.
- Radioprotective effects of amifostine on acute and chronic esophageal injury in rodents.
- The role of amifostine as a radioprotector.
- Topical application of WR-2721 to prevent radiation-induced proctosigmoiditis. A phase I/II trial.
- Toxicity, biodistribution and radioprotective capacity of L-homocysteine thiolactone in CNS tissues and tumors in rodents: comparison with prior results with phosphorothioates.